Golden Throat Holdings Group Company Limited (HKG:6896)

Market Cap	3.36B
Revenue (ttm)	1.26B
Net Income (ttm)	339.08M
Shares Out	739.30M
EPS (ttm)	0.46
PE Ratio	9.90
Forward PE	n/a
Dividend	0.50 (11.01%)
Ex-Dividend Date	Jun 16, 2025

Volume	1,281,500
Average Volume	933,800
Open	4.560
Previous Close	4.540
Day's Range	4.350 - 4.560
52-Week Range	2.900 - 5.650
Beta	0.28
RSI	29.91
Earnings Date	May 27, 2025

About HKG:6896

Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People’s Republic of China. It offers Golden Throat Lozenges over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. The company also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavours, such as orange, fructus momordicae, chrysanthemum, American gin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1956
• Employees: 874
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6896

Financial Performance

In 2024, HKG:6896's revenue was 1.19 billion, an increase of 23.26% compared to the previous year's 961.38 million. Earnings were 318.63 million, an increase of 27.37%.

Financial numbers in CNY